Search stocks

Find any stock by ticker or company name

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Kuzatuv
Bozorlar
Skriner
Yangiliklar
Biz haqimizda

LMAT - LeMaitre Vascular, Inc. So'nggi... | Finranks

Home

/

LMAT

L

LeMaitre Vascular, Inc. (LMAT)

NGM – Real vaqt narxi. Valyuta: USD

95.66

+1.73 (1.84%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

95.66

-0.00 (-0.00%)

Bozordan keyin: Jun 26, 2026, 4:31 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Casey's & 3 More Stocks With Strong Interest Coverage to Buy Now

Casey's & 3 More Stocks With Strong Interest Coverage to Buy Now

CASY, CLS, PNTG and LMAT stand out for strong interest coverage as borrowing costs rise, with solid sales/EPS growth estimates and big one-year gains.

LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why

LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why

LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.

Portfolio Update - April Dividend Income Report

Portfolio Update - April Dividend Income Report

CGI reported a good quarter with revenue up 3.3% to $4.16B and diluted EPS up 10.6% to $2.09. Revenue growth was driven by acquisitions. ADP reported a strong quarter with revenue up 7% and adjusted EPS up 12%. Employer Services grew 7% to $3.3B on strong client retention and new business bookings. Since I started this portfolio in September 2017, I have received a total of $36,112.67 CAD in dividends.

LeMaitre to Participate at Upcoming Investor Conferences in June

LeMaitre to Participate at Upcoming Investor Conferences in June

BURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two upcoming investor conferences in June.

Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround

Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround

LeMaitre (LMAT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

LeMaitre to Present at the Bank of America Healthcare Conference

LeMaitre to Present at the Bank of America Healthcare Conference

BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM PT.

3 Reasons Growth Investors Will Love LeMaitre (LMAT)

3 Reasons Growth Investors Will Love LeMaitre (LMAT)

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Videolar

Final Trade: LMAT, REGN, BA, TJX

Press-relizlar

LeMaitre Q1 2026 Financial Results

LeMaitre Q1 2026 Financial Results

BURLINGTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance.

LeMaitre Q4 2025 Financial Results

25.02.2026

LeMaitre Q4 2025 Financial Results

BURLINGTON, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q4 2025 results, announced a quarterly dividend of $0.25/share (+25%), and provided guidance.

LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026

LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026

BURLINGTON, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2025 financial results on Wednesday, February 25, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook.

LeMaitre Q3 2025 Financial Results

LeMaitre Q3 2025 Financial Results

BURLINGTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance.